Invention Grant
- Patent Title: Pyridiazinone derivatives for the treatment of tumours
- Patent Title (中): 吡哆醇酮衍生物用于治疗肿瘤
-
Application No.: US12096079Application Date: 2006-11-07
-
Publication No.: US08173653B2Publication Date: 2012-05-08
- Inventor: Dieter Dorsch , Oliver Schadt , Andree Blaukat
- Applicant: Dieter Dorsch , Oliver Schadt , Andree Blaukat
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent Gesellschaft MIT Beschraenkter Haftung
- Current Assignee: Merck Patent Gesellschaft MIT Beschraenkter Haftung
- Current Assignee Address: DE Darmstadt
- Agency: Millen, White, Zelano & Branigan, P.C.
- Priority: DE102005057924 20051205
- International Application: PCT/EP2006/010668 WO 20061107
- International Announcement: WO2007/065518 WO 20070614
- Main IPC: A01N43/58
- IPC: A01N43/58 ; A61K31/50 ; C07D237/02
Abstract:
Compounds of the formula (I), in which R1, R2 and R3 have the meanings indicated in claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for the treatment of tumors.
Public/Granted literature
- US20080293719A1 Pyridiazinone Derivatives for the Treatment of Tumours Public/Granted day:2008-11-27
Information query
IPC分类:
